Donn Casale
President and CEO, Director · ARS Pharmaceuticals, Inc.
Individual
- 2026
- Oct 5, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Donn Casale files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Justin Chakma - $1.48M in SPRY purchases and sales in the last 12 months
- Eric Karas - $250K in SPRY purchases and sales in the last 12 months
- Brian Dorsey - $190K in SPRY purchases and sales in the last 12 months
- Alexander A. Fitzpatrick - $34K in SPRY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Donn Casale?
Donn Casale is a corporate insider, tracked as President and CEO, Director of ARS Pharmaceuticals, Inc. (SPRY). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Donn Casale submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.